Diabetes 52:1591-1594, 2003
© 2003 by the American Diabetes Association, Inc.
Magnetic Resonance-Defined Periportal Steatosis Following Intraportal Islet Transplantation
A Functional Footprint of Islet Graft Survival?
James F. Markmann1,
Mark Rosen2,
Evan S. Siegelman2,
Michael C. Soulen2,
Shaoping Deng1,
Clyde F. Barker1, and
Ali Naji1
1 Department of Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania
2 Department of Radiology, University of Pennsylvania Health System, Philadelphia, Pennsylvania
There is growing interest in more widespread application of isolated islet transplantation for the treatment of type 1 diabetes; however, the sequelae of long-term islet residence within the liver are unknown. We report herein a consequence of intraportal islet transplantation, specifically the development of periportal hepatic steatosis apparently induced by the local secretion of insulin within the liver.
Address correspondence and reprint requests to James F. Markmann, MD, Department of Surgery, Hospital of the University of Pennsylvania, 4th Floor Silverstein, 3400 Spruce St., Philadelphia, PA 19104. E-mail: james.markmann{at}uphs.upenn.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Lee, M. Ravazzola, B.-H. Park, Y. K. Bashmakov, L. Orci, and R. H. Unger
Metabolic Mechanisms of Failure of Intraportally Transplanted Pancreatic {beta}-Cells in Rats: Role of Lipotoxicity and Prevention by Leptin
Diabetes,
September 1, 2007;
56(9):
2295 - 2301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Meier, I. Hong-McAtee, R. Galasso, J. D. Veldhuis, A. Moran, B. J. Hering, and P. C. Butler
Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver.
Diabetes,
August 1, 2006;
55(8):
2324 - 2332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R.T. Lakey, and A.M. J. Shapiro
Five-Year Follow-Up After Clinical Islet Transplantation
Diabetes,
July 1, 2005;
54(7):
2060 - 2069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Venturini, E. Angeli, P. Maffi, P. Fiorina, F. Bertuzzi, M. Salvioni, F. De Cobelli, C. Socci, L. Aldrighetti, C. Losio, et al.
Technique, Complications, and Therapeutic Efficacy of Percutaneous Transplantation of Human Pancreatic Islet Cells in Type 1 Diabetes: The Role of US
Radiology,
February 1, 2005;
234(2):
617 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bhargava, P. A. Senior, T. E. Ackerman, E. A. Ryan, B. W. Paty, J. R.T. Lakey, and A.M. J. Shapiro
Prevalence of Hepatic Steatosis After Islet Transplantation and Its Relation to Graft Function
Diabetes,
May 1, 2004;
53(5):
1311 - 1317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Harlan
Gene-Altered Islets for Transplant: Giant Leap or Small Step?
Endocrinology,
February 1, 2004;
145(2):
463 - 466.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|